Evidence map›Paper›PMID 40222549›Full record

ArticleOphthalmology2025

Genetic Risk for Open-Angle Glaucoma Subtypes Is Associated with Specific Visual Field Defect Classes.

Sayuri Sekimitsu, Kavin Selvan, Yan Zhao, Saber Kazeminasab Hashemabad, Mohammad Eslami, Mengyu Wang, Tobias Elze, Ayellet V Segrè, Joni A Turunen, Aarno Palotie and 5 more

Abstract read
In one paragraph

Article in Ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sayuri SekimitsuDepartment of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Kavin SelvanVirginia Commonwealth University School of Medicine, Richmond, Virginia.
Yan ZhaoDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Saber Kazeminasab HashemabadSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Mohammad EslamiSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Mengyu WangSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Tobias ElzeSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Ayellet V SegrèDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Joni A TurunenEye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Aarno PalotieDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Joel RämōDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Janey L WiggsDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Louis R PasqualeDepartment of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York.
Jae H KangBrigham and Women's Hospital, Boston, Massachusetts.
Nazlee ZebardastDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts. Electronic address: Nazlee_Zebardast@meei.harvard.edu.

Funding

Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
Understanding the clinical impact of cumulative genetic risk to glaucomaR01EY032559 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Louis Robert Pasquale, Janey L Wiggs · 2021 to 2026
$4.3M
Multiomic Framework for GlaucomaR01EY036460 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JAE H KANG, Louis Robert Pasquale · 2024 to 2026
$2.4M
Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine LearningR01EY036518 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Nazlee Zebardast · 2024 to 2026
$2.0M
Glaucoma Risk Prediction Using Machine Learning Integration of Image-Based Phenotypes and Genetic AssociationsK23EY032634 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI ZEBARDAST, NAZLEE · 2021 to 2024
$1.0M
NEI NIH HHS K23 EY032634NEI NIH HHS R01 EY015473NEI NIH HHS R01 EY032559NEI NIH HHS R01 EY036460NEI NIH HHS R01 EY036518
6 · The paper itself

Abstract

purposeWe investigated visual field (VF) archetype-genotype associations for open-angle glaucoma (OAG) and its subtypes, high-tension glaucoma (HTG) and normal-tension glaucoma (NTG).

designCross-sectional, population-based study.

participantsA total of 79 357 VF results from 11 572 patients with OAG at Massachusetts Eye and Ear (2012-2022) were used to identify VF archetypes. Archetype-genotype correlations were performed on participants with genotyping data, VF results, and OAG codes (H40.1x) from the Mass General Brigham Biobank, and 3 Health Professional Cohorts (n = 1517) with primary open-angle glaucoma (POAG) and reproducible VF loss.

methodsPrimary open-angle glaucoma polygenic risk score (PRS), NTG PRS, and weighted HTG genetic risk score (GRS) from genome-wide association studies were calculated for 1517 participants (2408 eyes). Logistic regression assessed VF archetype-genotype associations.

main outcome measuresAssociations between PRS or GRS and VF archetypes.

resultsNine archetypes were identified, including normal and various paracentral, peripheral, and total loss patterns. In a logistic regression model adjusted for age, sex, and ancestry, a 1-standard deviation (SD) increase in POAG PRS was linked to 1.65-times higher odds of paracentral defects (adjusted odds ratio [aOR], 1.65; 95% confidence interval [CI], 1.32-2.08) and 1.30-times higher odds of peripheral defects (aOR, 1.3; 95% CI, 1.14-1.48). A 1-SD increase in NTG PRS was associated with 1.69-times higher odds of paracentral defects (aOR, 1.69; 95% CI, 1.23-2.3) and 1.28-times higher odds of peripheral defects (aOR, 1.28; 95% CI, 1.06-1.54). A 1-SD increase in HTG GRS was linked to 0.68-times lower odds of both paracentral defects (aOR, 0.68; 95% CI, 0.57-0.82) and peripheral defects (aOR, 0.68; 95% CI, 0.62-0.76). A 1-SD increase in HTG GRS also was associated with 1.31-times higher odds of total loss (OR, 1.31; 95% CI, 1.01-1.77) in an unadjusted model, but was not significant in the adjusted model.

conclusionsHigher POAG PRSs and NTG PRSs were associated with paracentral VF loss, whereas higher HTG GRS was linked to total VF loss, but not paracentral defects. Genetic risk for glaucoma subtypes is associated with specific VF defects, which may affect disease diagnosis and prognostication. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Genetic Risk ScoreGlaucoma, Open-AngleVision DisordersVisual FieldsAdultAgedCross-Sectional StudiesDatasets as TopicFemaleFollow-Up StudiesGenome-Wide Association StudyGenotyping TechniquesHumansIntraocular PressureLogistic ModelsLongitudinal StudiesGenetic riskGlaucomaPolygenic riskVisual field

Identifiers

PMID40222549
PMCPMC13007528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.